当前位置: 首页 >> 检索结果
103. Predatory Journals: What Can We Do to Protect Their Prey?
作者: Christine Laine.;Dianne Babski.;Vivienne C Bachelet.;Till W Bärnighausen.;Christopher Baethge.;Kirsten Bibbins-Domingo.;Frank Frizelle.;Laragh Gollogy.;Sabine Kleinert.;Elizabeth Loder.;João Monteiro.;Eric J Rubin.;Peush Sahni.;Christina C Wee.;Jin-Hong Yoo.;Lilia Zakhama.
来源: Ann Intern Med. 2025年178卷2期294-296页 104. Incorporating Economic Evidence in Clinical Guidelines: A Framework From the Clinical Guidelines Committee of the American College of Physicians.
作者: Amir Qaseem.;Tatyana Shamliyan.;Douglas K Owens.;Jeffrey A Tice.;Carolyn J Crandall.; .;Lauri A Hicks.;Timothy J Wilt.;Ethan M Balk.;Thomas G Cooney.;J Thomas Cross.;Nick Fitterman.;Johanna Lewis.;Jennifer S Lin.;Amy Linsky.;Michael Maroto.;Matthew C Miller.;Adam J Obley.;Paul Shekelle.;Janice E Tufte.;Itziar Etxeandia-Ikobaltzeta.;Curtis S Harrod.;Jennifer Yost.;Amir Qaseem.;Tatyana Shamliyan.;Carolyn J Crandall.;Douglas K Owens.;Jeffrey A Tice.
来源: Ann Intern Med. 2025年178卷2期241-248页
In recognition of accelerating health care spending and alignment with the American College of Physicians (ACP) principles of promoting high-value care, the ACP Clinical Guidelines Committee (CGC) developed a framework to standardize its approach to identifying, appraising, and considering economic evidence in the development of ACP clinical guidelines. This article presents the CGC's process for incorporating economic evidence, which encompasses cost-effectiveness analyses, economic outcomes in randomized controlled trials, and resource utilization (intervention cost) data. Economic evidence is one component of ACP recommendations. The CGC first and foremost assesses the certainty of evidence for clinical net benefit of interventions; it then considers patient values and preferences, and only then considers economic evidence to develop recommendations.
107. Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.
作者: .;Claire L Vale.;Peter J Godolphin.;David J Fisher.;Julian P T Higgins.;Alexandra McAleenan.;Francesca Spiga.;Tobias Tritschler.;Pedro Gabriel Melo de Barros E Silva.;David D Berg.;Jeffrey S Berger.;Lindsay R Berry.;Behnood Bikdeli.;Marc Blondon.;Erin A Bohula.;Marco Cattaneo.;Riccardo Colombo.;Valeria Coluccio.;Maria T DeSancho.;Michael E Farkouh.;Valentin Fuster.;Massimo Girardis.;Judith S Hochman.;Thomas P Jensen.;Vivekanand Jha.;Peter Jüni.;Ajay J Kirtane.;Patrick Lawler.;Grégoire Le Gal.;Ramon Lecumberri.;Steven R Lentz.;Renato D Lopes.;Elizabeth Lorenzi.;Marco Marietta.;Carlos Henrique Miranda.;Nuccia Morici.;Susan C Morpeth.;David A Morrow.;Zoe K McQuilten.;Nuria Muñoz-Rivas.;Matthew D Neal.;Suman Pant.;Sahil A Parikh.;Usha Perepu.;Parham Sadeghipour.;Sanjum Sethi.;Michelle Sholzberg.;Alex C Spyropoulos.;Gregg W Stone.;Azita Hajhossein Talasaz.;Steven Tong.;James Totterdell.;Balasubramanian Venkatesh.;Maddalena Alessandra Wu.;Ryan Zarychanski.;Stephane Zuily.;Julie Viry.;Jamie Rylance.;Neill K J Adhikari.;Janet V Diaz.;John C Marshall.;Jonathan A C Sterne.;Srinivas Murthy.
来源: Ann Intern Med. 2025年178卷1期59-69页
Reported results of clinical trials assessing higher-dose anticoagulation in patients hospitalized for COVID-19 have been inconsistent.
113. Strategies to Address Racial and Ethnic Disparities in Health and Health Care for Chronic Conditions : An Evidence Map of Research From 2017 to 2024.
作者: Toyin Lamina.;Hamdi I Abdi.;Kathryn Behrens.;Romil Parikh.;Kathleen Call.;Amy M Claussen.;Janette Dill.;Stuart W Grande.;Laura Houghtaling.;Rhonda Jones-Webb.;Manka Nkimbeng.;Elizabeth A Rogers.;Shahnaz Sultan.;Rachel Widome.;Timothy J Wilt.;Mary Butler.
来源: Ann Intern Med. 2025年178卷1期88-97页
Racial and ethnic disparities in health and health care persist in the United States, adversely affecting outcomes in prevention and treatment of chronic conditions among adults.
114. Clinical Characteristics and Current Management of U.S. Adults at Elevated Risk for Heart Failure Using the PREVENT Equations: A Cross-Sectional Analysis.
作者: Jeremy B Sussman.;Linnea M Wilson.;James F Burke.;Boback Ziaeian.;Timothy S Anderson.
来源: Ann Intern Med. 2025年178卷1期144-147页 115. Development and Evaluation of a Comprehensive Prediction Model for Incident Coronary Heart Disease Using Genetic, Social, and Lifestyle-Psychological Factors: A Prospective Analysis of the UK Biobank.
作者: Mohammadreza Naderian.;Kristjan Norland.;Daniel J Schaid.;Iftikhar J Kullo.
来源: Ann Intern Med. 2025年178卷1期1-10页
Clinical risk calculators for coronary heart disease (CHD) do not include genetic, social, and lifestyle-psychological risk factors.
|